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Tuberculosis is the leading cause of death in adults from a single infectious agent, killing
about 3 million people every year. One-third of the human population is thought to be
infected by the causative agentMycobacterium tuberculosis. Multidrug resistance isolates are
one of the most important concerns in tuberculosis control. In this study, we used MIRU-
VNTR to determine MDR-TB transmission in Tabriz. A hundred and twenty M. tuberculosis
isolates were collected from patients who referred to TB center of Tabriz and characterized
for drug resistance and typing by MIRU-VNTR method. Thirty percent of the isolates were
resistant to at least one drug. Among Iranian isolates only two isolates (1.9%) were MDR
and in patients from the Republic of Azerbaijan four isolates (28.6%) were MDR. By MIRU-
VNTR typing eighty eight distinct profiles were identified, including 20 clustered profiles
and 68 unique patterns and fifty two isolates (43.3%) included in clusters. The minimum
estimate of the proportion of tuberculosis transmission in East Azerbaijan with MIRU-
VNTR was 26.7% and 14% of MDR isolates acquired infections recently. Results of the
present study showed that high percent of TB cases are sensitive to antibiotics. MIRU-
VNTR typing showed a limited number of MDR-TB transmission in our isolates set.
Because of the increasing number of patients referred from Rep. of Azerbaijan with MDR-
TB, we need more stewardship and controlling programs for these patients for preventing
the outbreak of MDR-TB in our region.
Copyright 2014, Beni-Suef University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The importance of the tuberculosis (TB) a major infectious
disease and a cause of high morbidity and mortality has been5.
. Kafil).
i-Suef University.
ity. Production and hostcompletely recognized (Asgharzadeh et al., 2011). Countless
millions of people have died from tuberculosis, a chronic in-
fectious disease caused by the tubercle bacillus (Cole et al.,
1998). The World Health Organization (WHO) estimated that
there were about 450,000 new multidrug-resistance (MDR)-TBing by Elsevier B.V. All rights reserved.
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estimated to have occurred in 2012 (WHO, 2013). About 10% of
MDR-TB cases were XDR-TB (Extensively drug-resistant-TB).
By September 2013, 92 countries had reported at least one
XDR-TB cases [3]. MDR-TB is caused by resistance to isoniazid
(INH) and rifampin (RF) (Mokrousov et al., 2003) and exten-
sively drug-resistant (XDR)-TB is caused by Mycobacterium
tuberculosis isolates resistant to rifampin and isoniasid and
fluoroquinolone, and one of the three injectable drugs, cap-
reomycin, kanamycin and amikacin (Gandhi et al., 2010a).
MDR-TB is a problem both in the developed as well as in the
developing countries. The problem is even more serious
among the human immunodeficiency virus (HIV) infected
population (Gandhi et al., 2010b; Wells et al., 2007). Although
treatment of MDR is possible with currently available diag-
nostic techniques and drugs, the treatment course is sub-
stantially more close and laborious than from drug
susceptible tuberculosis, with higher rates of treatment fail-
ure and mortality (Gandhi et al., 2010a).
Mycobacterial interspersed repetitive unit-variable num-
ber tandem repeat (MIRU-VNTR) is an invaluable tool for
genotyping MIRU-VNTR revealed more transmission and
clusters (Asgharzadeh et al., 2008; Mazars et al., 2001).Fig. 1 e East Azarbaijan province of Iran in neighborhoThe province of East Azarbaijan is located in NorthWest of
Iran and neighbor with republic of Azarbaijan (Fig. 1). The
estimated population of the province is approximately
3,730,000 of which about 40% are inhabitants of Tabriz, the
capital city of the province.
Based on the report of WHO, the Republic of Azerbaijan is
one of high TB and MDR-TB burden countries (WHO, 2013),
and Azeri patients travel to Tabriz for treatment of TB. In
Tabriz, the TB surveillance is based on conventional methods
which can't identify the source of infection and discriminate
between new and old infections. Thereby, in this study, we
used MIRU-VNTR to determine MDR-TB transmission in
Tabriz.2. Material and methods
2.1. Patients population and bacterial isolates
All isolates ofM. tuberculosiswere collected from patients who
referred to TB center of Tabriz. The study population
comprised all patients from whom at least one sample was
positive for M. tuberculosis by culture. 120 isolates of M.od of Rep. Azerbaijan, Armenia, Turkey and Iraq.
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of Azerbaijan and 106 patients were from East Azerbaijan of
Iran.
Clinical isolates were recovered from sputum (N ¼ 92),
bronchial fluids (N ¼ 19), Cerebrospinal fluids (N ¼ 2), Urine
(N ¼ 2), neck mass biopsy (N ¼ 1), endometrial biopsy (N ¼ 1)
and pleural fluid (N ¼ 1). All isolates were cultured in low-
enstein jensen medium. The species identification of the iso-
lates was based on standard biochemical tests, including
production of niacin, catalase activity, nitrute reduction, and
pigment production and growth rate. The susceptibilities of
isolates to INH, RF, Streptomycin (SM), and ethambutol (ETB)
were determined by the proportion method (Rieder et al.,
1998). Information about age, sex, geographical origin and
history of tuberculosis were collected by the staffs of TB
center.2.2. DNA extraction
DNA used for the PCR analysis was extracted from culturedM.
tuberculosis. Two loops full of bacteria were suspended in
400 ml of TE buffer (10 mM Tris-cl, 1 mM EDTA, pH 8.0) and
placed at 80 C for 20 min to kill the bacteria. DNA was
extracted by lysozyme, SDS, proteinase K, NaCl, CTAB and
Chloroformeisoamylalcohol. Extracted DNA after sedimen-
tation with isopropanol and washing with ethanol 70% was
redissolved in 50 ml of dionized water and stored at 20 C
(Asgharzadeh et al., 2007).2.3. MIRU-VNTR
PCR was performed in 20 ml volume that contained 5e50 ng of
DNA, 0.5 mM of specific primers (Supply et al., 2001) in the
presence of 1.5 mM MgCl2, 100 mM of each dNTP, 50 mM KCl,
20 mM Tris-CL, pH 8.4, and 1.25 U recombinant Taq DNA po-
lymerase (Cinnagen, Iran). All PCRs were initiated by a 7 min
denaturation step at 94 C and completed by a 7min extension
step at 72 C. The temperature cycles for different types of
PCRs were as follows, 35 cycles of 45 s at 94 C, annealing
temperature for 45 s and final 72 C for 55 s. Annealing tem-
perature were used as follows: 65,63, 68, 65, 59, 67, 59, 65, 64,
63, 68 and 65 for MIRU loci 2, 4, 10, 16, 20, 23, 24, 26, 27, 31, 39
and 40 respectively (Supply et al., 2001). Negative controls
consisted of the PCR components of reaction mixture lacking
mycobacterial DNA. PCR products were electrophoresis in
1.5% agarose gel and after staining with 0.5 mg/ml ethidium
bromide in comparing with 100 bp-plus DNA ladders size
marker (Fermentas, Lithuania). Reference strain M. tubercu-
losis14323 was used as standard strain for PCR. MIRU-VNTRTable 1 e Traits of clustering tuberculosis in East Azarbaijan P
rifampin, SM: streptomycin, and ETB: ethambutol.
Trait No. of clustered
patients (%)
Resistance to any drug 5 (9.6)
Sensitive to Four drugs (INH, RF, SM, ETB) 47 (90.4)
Multidrug resistance 1 (1.9)
Non Multidrug resistance 51 (98.1)plus website was used for analyzing MIRU-VNTR results
(www.miru-vntrplus.org/).
2.4. Statistical analysis
All patients included were classified into two groups, clus-
tered and non-clustered. Categorical data were compared by
ChieSquare test (or Fisher exact test). P-value below 0.05 was
considered significant. The minimum estimate of the pro-
portion of tuberculosis caused by transmissionwas calculated
as (Godfrey-Faussett et al., 2000):
Number of clustered patients number of clusters
Total number of patients
3. Results
The age of the patients ranged from 12 to 90 years. Seventy
(58.3%) of the 120 isolates were susceptible to INH, RIF, SM and
ETB. Thirty percent of the isolates were found to be resistant
to at least one drug, with 22.5% of the isolateswere resistant to
STR, 10.83% were resistant to INH, 10% were resistant to RIF
and 3.33% were resistant to ETB. Among Iranian isolates only
two isolates (1.9%)wereMDR and in patients traveled from the
Republic of Azerbaijan four isolates (28.6%) were MDR.
Eighty eight distinct profiles were identified, including 20
clustered profiles and 68 unique patterns. Fifty two isolates
(43.3%) included in clusters (Table 1). In clusters, the largest
cluster comprised six patients. Eight clusters were comprised
of three patients and eleven clusters comprised of two pa-
tients. In MIRU-VNTR typing three clusters found to share a
similar profile with Azeri patients. One Azeri patient who was
35 years old and referred to our center for treatment in several
times, showed similar MIRU-VNTR profile with two Iranian
patients. The second cluster comprised one Iranian and one
Azeri patient who was resistant to SM, and the last cluster
included two Azeri patients, which bothwere resistance to SM
and one of them was resistant to INH (Fig. 2). The minimum
estimate of the proportion of tuberculosis that was due to
transmission in East Azerbaijan province of Iran with MIRU-
VNTR was 26.7% [(52e20)/120].4. Discussion
Treatment of MDR tuberculosis needs long time usage of toxic
drugs which is offensive for patients and is costly for patients
and governments. It's why identifying recent transmission of
MDR tuberculosis is one of concern topics especially inrovince of Iran. Abbreviations indicates: INH: isoniazid, RF:
No. of non-clustered
patients (%)
All patients (%) P-value
31 (45.6) 36 (30) P < 0.01
37 (54.4) 84 (70) P < 0.01
5 (7.35) 6 (5) P ¼ 0.1762
63 (92.65) 114 (95) P ¼ 0.1762
Fig. 2 e Clusters and distribution of isolates in phylogenetic tree. Color circles indicate clusters. Clusters with MDR isolates
and Azeri patients are explained in figure.
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MDR isolates of M. tuberculosis, all clinical isolates should be
typed by molecular methods and presence of isolates in the
same clusters reveals recent transmissions (van Deutekom
et al., 2005). In this study 43.3% of isolates included in clus-
ters which the biggest cluster contained six patients and the
rest of clusters included less patients including 2 or 3 patients.
This indicates that transmission of MDR tuberculosis is low in
East Azerbaijan province, of Iran and there is no sign of
transmission of resistant isolates in this region. By hypothesis
that all patients included in the same cluster, acquired in-
fections recently from one of cluster members, only 14% of
MDR isolates acquired infections recently, whereas it was
higher in a study by Frieden and colleagues in New York city
(Frieden et al., 1993), they concluded that the prevalence of
HIV and Drug abuse by injection caused high rate of MDR
transmission in their region. Also in some other regions like
Archangel in Russia (Toungoussova et al., 2002), Estonia
(Kru¨u¨ner et al., 2001), South Africa (Marais et al., 2006) trans-
mission rate of MDR tuberculosis were higher than present
study. But transmission of MDR-TB in Texas e USA (Wilson
et al., 1999) and Los Angles e California (Nitta et al., 2002)
they had the same rate of transmission thatwas due to patient
stewardship programs (Nitta et al., 2002). Several factors can
contribute in low rate of MDR-TB transmission in our region:
1) Beijing strains are more pathogen (Parwati et al., 2010) and
highly transmissible (Toungoussova et al., 2002), most of
MDR-TB isolates belonged to this genotype (Marais et al.,
2006), considering the fact that there is no Beijing strains
report from this province, therefore, it can justify less trans-
mission of MDR-TB in this region. 2) In this study, most of
clusters compromised lowmember and MDR isolates had less
tendency to be in clusters in comparing with sensitive iso-
lates. Previously Li et al. showed that Isoniasid resistant iso-
lates were less pathogen in guinea pig in comparing withsensitive isolates and mutation in KatG gene caused resis-
tance to Isoniasid and lower pathogenesis (Li et al., 1998). 3)
patients conditions have a direct effect on the emergence of
MDR isolates, this condition can be public welfare, prevalence
of HIV (Frieden et al., 1993), As reported before, MDR-TB is
more prevalent in regions with high prevalence of HIV infec-
ted patients (Frieden et al., 1993; Jafari-Khounigh et al., 2014),
in this province because of the low prevalence of HIV, we
expected less transmission of MDR-TB. 4) This province is a
pioneer in TB controlling programs in our country that caused
less contamination and transmission of MDR-TB in this
province.
This province host patients from several neighbor coun-
tries, mostly from Republic of Azerbaijan. In the present
study 67% of MDR isolates belonged to Patients from Republic
of Azerbaijan which have been referred to the Tabriz TB
center for treatment. They had not clear clinical background
and at least half of them had resistance to one or more an-
tibiotics and four of them had MDR-TB. Number of patients
referred from Rep. of Azerbaijan increased from 12% in 2003
to 22% in 2012. Rate of MDR-TB in East Azarbaijan was about
1.9% while the rate of MDR-TB in isolates from the Rep.
Azerbaijan was about 28.6%. Present study showed that rate
of TB transmission from Azerian patients to Iranian was
5.8%. Previous study as well as ours has shown 60.8% MDR-
TB isolation of Beijing strains from Rep. Azerbaijan (Pfyffer
et al., 2001). This high rate of MDR in this country is due to
the high cost of TB treatment and weak public health in-
frastructures, therefore, patients prefers Iranian hospitals
and health centers for treatment. According to longtime
recurrence nature of TB, and high prevalence of MDR-TB in
isolates from Rep. Azerbaijan, we will face with the outbreak
of MDR-TB in East Azarbaijan- Iran and we need Compre-
hensive program to monitor patients and controlling infec-
tion transmission.
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tuberculosis, which clustered in the same clusters can have
different resistance pattern and isolates will get resistance
because of inappropriate use of Antibiotics. In one of cluster
with three members, one of them was resistant to Strepto-
mycin and Isoniazid but the rest members were only resistant
to streptomycin. Also in a cluster with Azeri patient, Azerian
isolate was MDR but Iranian isolate was sensitive. This in-
dicates that isolate was sensitive in the first visit of Azerian
patients from Iran, but it Acquired resistance during the stay
on their country and probably inappropriate usage of
antibiotics.
Our limitations in this study included limited MIRU-VNTR
typed isolates that contained six month period isolates, that
with longer time we will have a clearer assessment of the TB
transmission condition in this region. Also we have some
limitation in antibiogram performance in our province. Also
patient's records were not registered completely like where
foreign patients are staying in Iran or with whom they have
contact. We hope to solve these obstacles for further studies.5. Conclusion
In conclusion, results of the present study showed that the
high percent of TB cases are sensitive to antibiotics. MIRU-
VNTR typing showed a limited number of MDR-TB trans-
mission in our isolates set. Because of the increasing number
of patients referred from Rep. of Azerbaijan with MDR-TB, we
need more stewardship and controlling these patients for
preventing the outbreak of MDR-TB in our region.
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